Enzolytics Breaks New Ground: Merger With BioClonetics Immunotherapeutics Is Compelling ENZC
Breakout Stocks Corona Virus Stocks Traders Tips The last month of a stunning year is still going strong for Enzolytics, Inc. (OTC: ENZC), which announced earlier this month that it has completed its merger with BioClonetics Immunotherapeutics. The result is an increasing demand for this volatile stock, which currently has a value of almost $0.09 per…